Investigating the utility of circulating-free tumor-derived DNA (ctDNA) in plasma for the detection of epidermal growth factor receptor mutation (EGFRM) status in German patients (pts) with advanced non-small-cell lung cancer (aNSCLC) - ASSESS study

被引：0
|
作者：
Reinmuth, N. [1 ]
Grohe, C. [2 ]
Seese, B. [3 ]
Schuette, W. [4 ]
Fischer, J. [5 ]
Randerath, W. [6 ]
Serke, M. [7 ]
Atanackovic, D. [8 ]
Brueckl, W. [9 ]
Normanno, N. [10 ]
Tiemann, M. [11 ]
Radke, S. [12 ]
Rupprecht, M. [12 ]
Heyne, M. [12 ]
Reck, M. [1 ]
机构：
[1] LungenClin Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
[2] Evangel Lungenklin Berlin, Berlin, Germany
[3] Thoraxzentrum Bezirk Unterfranken, Dept Pneumol, Munnerstadt, Germany
[4] Martha Maria Krankenhaus Halle Dolau, Halle, Germany
[5] Lungenklin Lowenstein, Lowenstein, Germany
[6] Krankenhaus Bethanien, Dept Pneumol & Allergol, Solingen, Germany
[7] Lungenklin Hemer, Dept Pneumol, Hemer, Germany
[8] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[9] Paracelsus Med Univ, Gen Hosp, Dept Internal Med 3, Nurnberg, Germany
[10] INT Fdn Pascale, Dept Res, Naples, Italy
[11] Hematopathol Hamburg, Hamburg, Germany
[12] AstraZeneca GmbH, Med Affairs, Wedel, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0321
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] INVESTIGATING THE UTILITY OF CIRCULATING-FREE TUMOUR-DERIVED DNA (CTDNA) IN PLASMA FOR THE DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION STATUS IN EUROPEAN AND JAPANESE PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG CANCER (ANSCLC): ASSESS STUDY
    Reck, M.
    Hagiwara, K.
    Han, B.
    Tjulandin, S.
    Grohe, C.
    Yokoi, T.
    Morabito, A.
    McCormack, R.
    Ratcliffe, M.
    Normanno, N.
    ANNALS OF ONCOLOGY, 2015, 26
  • [2] INVESTIGATING THE UTILITY OF PLASMA DERIVED CIRCULATING FREE DNA FOR THE DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN EUROPEAN AND JAPANESE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): ASSESS STUDY DESIGN
    Reck, Martin
    Hagiwara, Koichi
    Tjulandin, Sergei
    Han, Baohui
    Mcwalter, Gael
    Mccormack, Rose
    Normanno, Nicola
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S483 - S484
  • [3] Tyrosine kinase inhibitor (TKI) cessation in advanced non-small-cell lung cancer (aNSCLC) for improved detection of EGFR-mutated (EGFRm) circulating tumor DNA (ctDNA).
    Tabchi, Samer
    Forte, Stephanie
    Alameddine, Raafat
    Khazaka, Aline
    Florescu, Marie
    Weng, Xiaoduan
    Tehfe, Mustapha
    Blais, Normand
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Epidermal growth factor receptor mutation (EGFRm) testing in advanced non-small cell lung cancer (aNSCLC) in a real-world setting
    Subramanian, J.
    Gregg, J.
    Wang, H.
    Sun, P.
    Yu, B.
    Shenolikar, R.
    Chau, M.
    Taylor, A.
    Leighl, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S888 - S889
  • [5] Understanding epidermal growth factor receptor mutation (EGFRm) testing in patients (pts) with non-small cell lung
    Nadler, Eric
    Fernandes, Ancilla
    Pavilack, Melissa
    Amirian, Susan
    Clark, Jamyia
    Frytak, Jennifer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [6] Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non-Small-Cell Lung Cancer
    Sun, Hai-bo
    Ou, Wei
    Li, Yin
    Fang, Qin
    Qin, Jianjun
    Zhang, Liang
    Wang, Si-yu
    CLINICAL LUNG CANCER, 2013, 14 (04) : 376 - 382
  • [7] Utility of longitudinal circulating tumor DNA (ctDNA) modeling to predict RECIST-defined progression in first-line patients with epidermal growth factor receptor mutation-positive (EGFRm) advanced non-small cell lung cancer (NSCLC)
    Vishwanathan, Karthick
    Dunyak, James
    Overend, Philip
    Hartmaier, Ryan
    Markovets, Aleksandra
    Chmielecki, Juliann
    Mugundu, Ganesh
    Barrett, Carl
    Tomkinson, Helen
    Johnson, Martin
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
    Normanno, Nicola
    Denis, Marc G.
    Thress, Kenneth S.
    Ratcliffe, Marianne
    Reck, Martin
    ONCOTARGET, 2017, 8 (07) : 12501 - 12516
  • [9] Circulating free tumour-derived DNA (ctDNA) to detect EGFR mutation in patients (pts) with advanced NSCLC (aNSCLC): French subset analysis of the ASSESS study
    Denis, M. G.
    Lafourcade, M. P.
    Le Garff, G.
    Dayen, C.
    Falchero, L.
    Thomas, P.
    Locher, C.
    Fraboulet, G.
    Oliviero, G.
    Licour, M.
    Normanno, N.
    Reck, M.
    Molinier, O.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review
    Hu, Fang
    Mao, Xiaowei
    Zhang, Yujun
    Zheng, Xiaoxuan
    Gu, Ping
    Wang, Huimin
    Zhang, Xueyan
    ONCOTARGETS AND THERAPY, 2018, 11 : 1373 - 1384
12345